Showing results (51-60 of 1,274) with videos related to

Sort By:
Pageof 128
The American Journal of Pathology|July 5, 2001
HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?S Aractingi, N Briand, C Le Danff, et al.
Annales De Dermatologie Et De Venereologie|March 5, 2005
[Cicatricial pemphigoid: treatment with mycophenolate mofetil]S Ingen-Housz-Oro, C Prost-Squarcioni, F Pascal, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 6, 2022
Switches between biologics in patients with moderate-to-severe psoriasis: results from the French cohort PSOBIOTEQR Curmin, S Guillo, Y De Rycke, et al.
The British Journal of Dermatology|February 16, 2007
Treatment of refractory erosive oral lichen planus with extracorporeal photochemotherapy: 12 casesA D Guyot, D Farhi, S Ingen-Housz-Oro, et al.
The British Journal of Dermatology|January 17, 2007
A follow-up study in 28 patients treated with infliximab for severe recalcitrant psoriasis: evidence for efficacy and high incidence of biological autoimmunityN Poulalhon, E Begon, C Lebbé, et al.
Archives of Dermatology|September 1, 1995
Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndromeH Bachelez, L Bioul, B Flageul, et al.
Archives of Internal Medicine|July 14, 1997
Fulminant Pneumocystis carinii pneumonia in 4 patients with dermatomyositisH Bachelez, B Schremmer, J Cadranel, et al.
The British Journal of Dermatology|July 30, 2017
Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomized controlled, double-blind, 52-week, phase III trial in patients with moderate-to-severe plaque psoriasisK Papp, H Bachelez, A Costanzo, et al.
Dermatology (Basel, Switzerland)|January 25, 2013
HIV-related CD8+ cutaneous pseudolymphoma: efficacy of methotrexateS Ingen-Housz-Oro, E Sbidian, N Ortonne, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 17, 2019
Users of biologics in clinical practice: would they be eligible for phase III clinical studies? Cohort Study in the French Psoriasis Registry PSOBIOTEQM Masson Regnault, J Castañeda-Sanabria, M H T Diep Tran, et al.
Pageof 128